Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Patient evaluation

Use data collection practices to measure and evaluate restraint-related injuries as well as the overall use of restraints. Use continuous quality improvement processes to monitor no injury-related falls. [Pg.332]

Note Physically check every 15 min to ensure circulation. [Pg.332]


The nurse may request that the patient evaluate the pain using a standardized pain scale measurement tool. The pain is rated using a scale of 1 to 10, with 10 being the most severe pain and 1 being the least discomfort. Failure to adequately assess pain is a major factor in the undertreatment of pain. [Pg.172]

Schreiber K, Otura AB, Ryder LP, Madsen HO, Jorgensen OS, Svejgaard A, Sorensen PS (2002) Disease severity in Danish multiple sclerosis patients evaluated by MRI and three genetic... [Pg.143]

In the REACH smdy involving the Medical College of Georgia and five rural hospitals in Georgia, 12 of 75 (16%) patients evaluated received rt-PA, all without intracranial hemorrhagic complications. [Pg.221]

An educational, behavior modification approach should be taken with the patient. Education about chemical dependency is most important. Expected behavioral changes must be clearly conceived and communicated to the patient. Evaluation of vocational status and skill development require attention. [Pg.272]

Patient evaluation should include a thorough history of all medications and herbal or dietary supplements. [Pg.699]

A recent meta-analysis evaluated patients at doses of 15 and 30 mg daily. Patients were analyzed for periods of 2 to 24 weeks. The majority of patients enrolled were female, and more than 80% of the patients evaluated received adjunctive modification in lifestyle. An average weight loss of 3.6 kg (7.9 lbs) was demonstrated for patients treated with phentermine compared with placebo. Although modest in amount, this value was statistically significant.37... [Pg.1535]

Biosensors are analytical devices that incorporate a biological component and a transducer. These must be in close proximity with one another and preferably in intimate contact, i.e. the biological component immobilized on to the transducer. Such devices are available in disposable forms, e.g. for measurement of blood glucose in diabetic patients, evaluation of the freshness of uncooked meat. Other designs are suitable for continuous use, e.g. on-line monitoring of fermentation processes, the detection of toxic substances. [Pg.191]

Phase I evaluation of CP-724714 in cancer patients is ongoing [68]. The majority of patients in this trial have breast cancer and have received trastuzumab previously. The MTD was determined to be 250 mg with the dose-hmiting toxicity defined as hyperbilirubinemia and elevated liver enzymes. No objective responses have been reported for the 20 patients evaluated to date. Thirty-five percent of patients have experienced stable disease for an imdetermined period of time. In contrast to trastuzumab, cardiomyopathy has not been observed in this trial. [Pg.102]

The mechanism of action of this benzamide compoimd is not entirely understood but it has been shown to inhibit HDAC and cellular proUferation. It displays linear kinetics and is rapidly absorbed after oral administration. The main dose limiting toxicity (DLT) reported was thrombocytopenia with the MTD at 8 mg/m /day, although other toxicities Uke nausea, vomiting, diarrhea and fatigue were seen [136]. One partial response was seen in the 53 patients evaluated. [Pg.323]

Head injury/increased intracranial presswre.Buprenorphine may elevate cerebrospinal fluid (CSF) pressure use with caution in head injury, intracranial lesions, and other states where CSF pressure may be increased. Buprenorphine can produce miosis and changes in consciousness levels that may interfere with patient evaluation. [Pg.899]

The MACH-NC study included a subset analysis of six randomized trials of 861 patients evaluating neoadjuvant with or without adjuvant chemotherapy combined with radiotherapy vs concomitant/alternating chemotherapy. No significant benefit was associated with adjuvant or neoadjuvant chemotherapy. A trend in favor of concomitant or alternating chemoradiotherapy was found but was not determined to be statistically significant (p =... [Pg.161]

Sleep disorders are common, and are generally underdiagnosed. The two major complaints related to sleep are insomnia ( I can t sleep ) and excessive daytime sleepiness (EDS, I can t stay awake ). EDS is a relatively nonspecific symptom. It can be the end result of any factor that causes sleep disruption, and it can be caused by primary or intrinsic sleep disorders. Insomnia of any cause can result in sleep deprivation and subsequent EDS. The most common cause of EDS in the general population is self-imposed sleep deprivation, or insufficient sleep syndrome. By contrast, the most common causes of EDS seen in a sleep center are primary (intrinsic) disorders of EDS. The American Academy of Sleep Medicine (AASM, formerly the American Sleep Disorders Association) classification of sleep disorders includes over 80 diagnoses that are associated with EDS, but the majority of patients evaluated at sleep centers have sleep apnea, narcolepsy, idiopathic hypersomnia, or periodic limb movements of sleep. [Pg.2]

A handful of studies have examined actual work performance of residents in the fatigued state. In one of the only studies to look specifically at a clinical patient evaluation task (27), attending physicians compared the quality of the physician-... [Pg.343]

Although there are papers that discuss the relationships between cholesterol, lipid profiles, and major depression [34-39], there are few data that discuss the association between lipid profiles and depressive disorders with different phenotypes. Huang and Chen investigated the correlation between serum lipid, lipoprotein concentration, and major depressive disorder in patients evaluated for general health screening [41]. They found that analysis of covariance after age adjustment revealed significant differences in patients with melancholic feature and patients with atypical feature in serum concentrations of TG and VLDL in men and HDL in women [41]. However, there are still no reports that discuss the relationships between lipid profiles and major depression with postpartum onset or catatonic feature. In the future, large sample numbers will be needed to clarify the clinical differences in this field. [Pg.95]

In comatose patients evaluation of the oculomotor system relies on evaluation and observation of involuntary eye movements. The oculocephalic and the oculovestibular reflexes disappear in deep coma. [Pg.14]

Shohrati, M., Aslani, J., Eshraghi, M., Alaedini, F., Ghanei, M. (2008). Therapeutics effect of N-acetyl cysteine on mustard gas exposed patients evaluating clinical aspect in patients with impaired pulmonary function test. Respir. Med. 102 443-8. [Pg.917]

In an ongoing phase I evaluation of datelliptium (384), there have been observed no significant toxic effects (dry mouth, hemolysis, and hypotension) (289). The dose-limiting toxicity is local phlebitis (220 mg/m ). However, no antitumor response has been noticed thus far in the study. In another phase I trial of this new drug, similar low toxicity was observed (290). Hepatic toxicity was the only acute dose-limiting toxicity. Thus far, of 12 patients evaluated, there has been 1 minor response in a patient with metastatic cervical carcinoma and the stabilization of a patient with metastatic resistant rhabdomyosarcoma. [Pg.342]

If no improvement occurs, the remaining 5 mg (0.5 ml) edrophonium can be given and the patient evaluated for several more minutes. Doses higher than 10 mg do not produce any improvement of symptoms if lower doses fail to eUcit improvement. In ocular myasthenia without... [Pg.374]

Gulbis B, Van der Heijden J, van As H, Thiry P. Whole blood cyclosporin monitoring in liver and heart transplant patients Evaluation of the specificity of a fluorescence polarization immunoassay and an enzyme-multiplied immunoassay technique. J Pharm Biomed Anal 1997 15 957-63. [Pg.178]


See other pages where Patient evaluation is mentioned: [Pg.209]    [Pg.209]    [Pg.140]    [Pg.167]    [Pg.209]    [Pg.209]    [Pg.239]    [Pg.314]    [Pg.7]    [Pg.98]    [Pg.348]    [Pg.100]    [Pg.118]    [Pg.169]    [Pg.459]    [Pg.48]    [Pg.193]    [Pg.197]    [Pg.359]    [Pg.7]    [Pg.28]    [Pg.344]    [Pg.235]    [Pg.240]    [Pg.309]    [Pg.69]   
See also in sourсe #XX -- [ Pg.667 ]




SEARCH



Combined therapies patient evaluation

Evaluation of Patients With Inhalant Use Disorders

Evaluation of patients

Hyperlipidemia patient evaluation

Patient care plan evaluation

Patient evaluation/selection

© 2024 chempedia.info